1 asset in Spinal Cord Neoplasm
Therapeutic assets addressing Spinal Cord Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Olutasidenib Spinal Cord Neoplasm | Rigel Pharmaceuticals | P2 | CCC (53) |
Therapeutic assets addressing Spinal Cord Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Olutasidenib Spinal Cord Neoplasm | Rigel Pharmaceuticals | P2 | CCC (53) |